{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:15:04Z","timestamp":1783588504351,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,9]]},"DOI":"10.7759\/cureus.112317","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:33:15Z","timestamp":1783585995000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Stevens-Johnson Syndrome Following Inadvertent Re-exposure to Cotrimoxazole: A Preventable Adverse Drug Reaction"],"prefix":"10.7759","author":[{"given":"Niva","family":"Doshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Brahmbhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2727.208261","article-title":"Cotrimoxazole, a wonder drug in the era of multiresistance: case report and review of literature","volume":"9","author":"Batra P","year":"2017","unstructured":"Batra P, Deo V, Mathur P, Gupta AK. Cotrimoxazole, a wonder drug in the era of multiresistance: case report and review of literature. J Lab Physicians. 2017, 9:210-3. 10.4103\/0974-2727.208261","journal-title":"J Lab Physicians"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20241601","article-title":"Co-trimoxazole induced Steven Johnson syndrome in HIV infected patient: things to consider","volume":"12","author":"Kunti DPSA","year":"2024","unstructured":"Kunti DPSA, Suryana K. Co-trimoxazole induced Steven Johnson syndrome in HIV infected patient: things to consider. Int J Res Med Sci. 2024, 12:2594-6. 10.18203\/2320-6012.ijrms20241601","journal-title":"Int J Res Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.6378","article-title":"Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis. A systematic review and meta-analysis","volume":"159","author":"Lee EY","year":"2023","unstructured":"Lee EY, Knox C, Phillips EJ. Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis. A systematic review and meta-analysis. JAMA Dermatol. 2023, 159:384-92. 10.1001\/jamadermatol.2022.6378","journal-title":"JAMA Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.9679","article-title":"Co-trimoxazole-induced toxic epidermal necrolysis: a case report from Nepal","volume":"12","author":"Gaire S","year":"2024","unstructured":"Gaire S, Chhetri ST. Co-trimoxazole-induced toxic epidermal necrolysis: a case report from Nepal. Clin Case Rep. 2024, 12:e9679. 10.1002\/ccr3.9679","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13445","article-title":"Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database","volume":"84","author":"Lebrun-Vignes B","year":"2018","unstructured":"Lebrun-Vignes B, Guy C, Jean-Pastor MJ, Gras-Champel V, Zenut M. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database. Br J Clin Pharmacol. 2018, 84:331-8. 10.1111\/bcp.13445","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas B","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al.. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010, 88:60-8. 10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1735242","article-title":"Predictive value of a severity-of-illness score for toxic epidermal necrolysis (SCORTEN) factors for in-hospital mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"12","author":"Nikitina E","year":"2025","unstructured":"Nikitina E, Dushkin A, Streltsov Y, et al.. Predictive value of a severity-of-illness score for toxic epidermal necrolysis (SCORTEN) factors for in-hospital mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis. Front Med (Lausanne). 2025, 12:1735242. 10.3389\/fmed.2025.1735242","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.191134","article-title":"Guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis: an Indian perspective","volume":"82","author":"Gupta LK","year":"2016","unstructured":"Gupta LK, Martin AM, Agarwal N, et al.. Guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis: an Indian perspective. Indian J Dermatol Venereol Leprol. 2016, 82:603-25. 10.4103\/0378-6323.191134","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4320195","article-title":"The epidemiology of Stevens\u2010Johnson syndrome and toxic epidermal necrolysis in China","volume":"2018","author":"Yang SC","year":"2018","unstructured":"Yang SC, Hu S, Zhang SZ, Huang JW, Zhang J, Ji C, Cheng B. The epidemiology of Stevens\u2010Johnson syndrome and toxic epidermal necrolysis in China. J Immunol Res. 2018, 2018:4320195. 10.1155\/2018\/4320195","journal-title":"J Immunol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management","volume":"25","author":"Shah H","year":"2024","unstructured":"Shah H, Parisi R, Mukherjee E, Phillips EJ, Dodiuk-Gad RP. Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management. Am J Clin Dermatol. 2024, 25:891-908. 10.1007\/s40257-024-00889-6","journal-title":"Am J Clin Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2025.03.002","article-title":"Reintroduction of cotrimoxazole in a Stevens-Johnson case with other antibacterial sulfonamide (sulfadiazine) among suspects","volume":"80","author":"Matei I","year":"2025","unstructured":"Matei I, Beaulieu V, Ollivier C, Lebrun-Vignes B, Bel Hareth K, Ingen-Housz-Oro S, Assier H. Reintroduction of cotrimoxazole in a Stevens-Johnson case with other antibacterial sulfonamide (sulfadiazine) among suspects. Therapie. 2025, 80:613-5. 10.1016\/j.therap.2025.03.002","journal-title":"Therapie"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau JC","year":"1994","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994, 331:1272-85. 10.1056\/NEJM199411103311906","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-013-2694-y","article-title":"Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis [Article in German]","volume":"65","author":"Mockenhaupt M","year":"2014","unstructured":"Mockenhaupt M. Severe drug-induced skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis [Article in German]. Hautarzt. 2014, 65:415-23. 10.1007\/s00105-013-2694-y","journal-title":"Hautarzt"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom BL","year":"2003","unstructured":"Strom BL, Schinnar R, Apter AJ, et al.. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003, 349:1628-35. 10.1056\/NEJMoa022963","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/09246479241292014","article-title":"Febuxostat induced Stevens Johnson syndrome: a case report","volume":"35","author":"Sidhu JK","year":"2024","unstructured":"Sidhu JK, Chopra D. Febuxostat induced Stevens Johnson syndrome: a case report. Int J Risk Saf Med. 2024, 35:334-6. 10.1177\/09246479241292014","journal-title":"Int J Risk Saf Med"},{"key":"ref17","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992, 49:2229-32.","journal-title":"Am J Hosp Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/470168-recurrent-stevens-johnson-syndrome-following-inadvertent-re-exposure-to-cotrimoxazole-a-preventable-adverse-drug-reaction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:33:15Z","timestamp":1783585995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/470168-recurrent-stevens-johnson-syndrome-following-inadvertent-re-exposure-to-cotrimoxazole-a-preventable-adverse-drug-reaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.112317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}